Lancet
-
Randomized Controlled Trial Multicenter Study Comparative Study Clinical Trial
Mesh versus suture repair of umbilical hernia in adults: a randomised, double-blind, controlled, multicentre trial.
Both mesh and suture repair are used for the treatment of umbilical hernias, but for smaller umbilical hernias (diameter 1-4 cm) there is little evidence whether mesh repair would be beneficial. In this study we aimed to investigate whether use of a mesh was better in reducing recurrence compared with suture repair for smaller umbilical hernias. ⋯ Department of Surgery, Erasmus University Medical Center, Rotterdam, Netherlands.
-
Randomized Controlled Trial Multicenter Study Comparative Study
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.
Intensive antiplatelet therapy with three agents might be more effective than guideline treatment for preventing recurrent events in patients with acute cerebral ischaemia. We aimed to compare the safety and efficacy of intensive antiplatelet therapy (combined aspirin, clopidogrel, and dipyridamole) with that of guideline-based antiplatelet therapy. ⋯ National Institutes of Health Research Health Technology Assessment Programme, British Heart Foundation.
-
Randomized Controlled Trial Multicenter Study Comparative Study
Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies.
Lifelong HIV antiretroviral therapy (ART) has prompted an interest in two-drug regimens to minimise cumulative drug exposure and toxicities. The safety, tolerability, and efficacy of dolutegravir and rilpivirine suggest potential compatibility and effectiveness as a two-drug regimen. We aimed to investigate this two-drug regimen in a phase 3 study. ⋯ ViiV Healthcare and Janssen Pharmaceutica NV.